Skip to content

Search

Results for {phrase} ({results_count} of {results_count_total})

Displaying {results_count} results of {results_count_total}

Generic filters

Hidden label

Exact matches only

Hidden label

Search in title

Hidden label

Search in content

Hidden label

Search in excerpt

About
Specialty Areas
Blog
Clinical Program
- Our Clinicians
- Make an Appointment
Research Program
Resources
- COVID-19 Mental Health Resources
- Suicide Prevention and Awareness Resources
Educational Programs
- CME Opportunities through MGH Psychiatry Academy
- Virtual Rounds at the CWMH
Contact
- Contact Us
- Support Our Program

Search

Results for {phrase} ({results_count} of {results_count_total})

Displaying {results_count} results of {results_count_total}

Generic filters

Hidden label

Exact matches only

Hidden label

Search in title

Hidden label

Search in content

Hidden label

Search in excerpt

Clinical Update

Clinical Update 2020: Lamotrigine (Lamictal) and Pregnancy

Clinical Update 2020: Lamotrigine (Lamictal) and Pregnancy Maintenance treatment with a mood stabilizer during pregnancy can significantly reduce the risk of relapse in women with bipolar disorder; however, many of the mood stabilizers commonly [...]

By MGH Center for Women's Mental Health|2020-07-27T13:00:03-04:00July 28th, 2020|Clinical Update, Pregnancy Outcomes, Psychiatric Disorders During Pregnancy|0 Comments

Clinical Update 2020: Antipsychotic Medications and Risk of Gestational Diabetes

Given the number of younger women using atypical antipsychotic medications, there is an urgent need for more accurate data regarding the reproductive safety of these medications. One important question is whether these newer antipsychotic [...]